Equity | Sector Specific - Pharma
3Y Returns
NA
Min SIP
₹500
Min Lumpsum
₹5000
Expense Ratio
%
Fund Size
₹N/A Cr
Inception Date
Fund Manager
Exit Load
.
Overall Fund Zi Tag
Asset Allocation
Equity
0.00%
Debt & Others
100.00%
Market Cap Allocation
Large Cap
50.57%
Mid Cap
24.07%
Small Cap
24.67%
Other Cap
0.69%
Investment Objective
Sbi Healthcare Opportunities Fund Direct Growth
1Y
57.22%
3Y
25.04%
5Y
30.93%
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Plan Growth
1Y
62.44%
3Y
24.78%
5Y
32.09%
Dsp Healthcare Fund - Direct - Growth
1Y
58.01%
3Y
23.18%
5Y
32.97%
Tata India Pharma And Healthcare Fund Direct Plan Growth
1Y
56.41%
3Y
22.85%
5Y
29.43%
Uti Healthcare Fund - Direct Growth Plan
1Y
58.48%
3Y
21.53%
5Y
29.6%
Mirae Asset Healthcare Fund - Direct Plan - Growth
1Y
54.99%
3Y
20.69%
5Y
31.41%
Nippon India Pharma Fund Direct Plan Growth Plan - Growth Option Growth
1Y
49.83%
3Y
20.69%
5Y
29.34%
Aditya Birla Sunlife Life Pharma And Healthcare Fund Direct Growth
1Y
52.38%
3Y
20.04%
5Y
26.38%
Lic Healthcare Fund - Direct Plan - Growth
1Y
NA
3Y
0.97%
5Y
14.14%
Quant Healthcare Fund - Direct Plan Growth - Growth
1Y
58.78%
3Y
NA
5Y
NA
Woc Pharma And Healthcare Fund - Direct Plan - Growth
1Y
NA
3Y
NA
5Y
NA
Kotak Healthcare Fund-Direct Plan-Growth
1Y
NA
3Y
NA
5Y
NA
Hdfc Pharma And Healthcare Fund - Growth Option - Direct Plan
1Y
65.29%
3Y
NA
5Y
NA
Iti Pharma And Healthcare Fund - Direct Plan - Growth
1Y
59.98%
3Y
NA
5Y
NA
BSE Member code: 58371
Wealthzi Investment Advisers (A division of Lime Internet Private Limited)
[CIN: U74999DL2017PTC310507] [PAN: AADCL2103M] [GSTIN: 07AADCL2103M1ZP]
[SEBI Registered Name: Lime Internet Private Limited] [SEBI RIA Registration No: INA000018133] [BASL Member ID: 2014] [Type of Registration: Non-Individual] [Validity of Registration: Perpetual] [Registered Address: Flat No. 603, 6th Floor, Kanchenjunga Building, 18 Barakhamba Road, New Delhi - 110001] [Principal Officer: Jyoti Prakash Nayak, Email: [email protected]] [Compliance Officer: Harshit Singh, Email: [email protected]] [Grievance Officer: Sanjeev Johari, Email: [email protected]]
[SEBI Regional Office Address: Securities and Exchange Board of India, NBCC Complex, Office Tower-1, 8th Floor, Plate B, East Kidwai Nagar, New Delhi - 110023, Ph: 011-69012998, Email: [email protected]]
Disclaimers:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI, membership of BASL and certification from National Institute of Securities Markets (NISM) in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
The information is only for consumption by the client and such material should not be redistributed.